A roadmap for research in medical physics via academic medical centers: The DIVERT Model
A roadmap for research in medical physics via academic medical centers: The DIVERT Model
复制标题
DOI：
10.1002/mp.14849
复制
发表时间：
2021-04-07
期刊：
影响因子：
3.8
通讯作者：
Gladstone, David J.
中科院分区：
文献类型：
--
作者：
Pogue, Brian W.;Zhang, Rongxiao;Gladstone, David J.
近年来，医学物理学领域一直在努力发挥研究的作用，因为专业兴趣主导了其向临床服务的发展。本文重点介绍学术医疗中心内的医学物理学课程的子集，以及这些中心内重新聚焦的学术使命如何通过风险投资和研究翻译工程（DIVERT）推动和支持发现和发明。一个路线图，以多元化为基础的学术研究计划在这里讨论的核心积木：（一）在研究和团队建设的创造力，（B）改进质量指标，以评估活动，（c）战略伙伴关系和分拆方向，扩展能力，（d）由教师主导的举措驱动的未来方向。在学术界，这是教师的独特发现和发明，导致他们作为学者的认可，并导致他们的研究计划和他们的智力贡献的reconition的财政支持。创新还必须与翻译相结合，以展示成果的成功。这些因素对研究资金至关重要，生物医学工程研究资金的20年增长就是一个例证，技术发明一直是目标。这一记录可以与放射肿瘤学和放射学的平坦资助形成对比，其中越来越多的研究是基于程序的。然而，一些中心正在通过纳入或吸收生物医学工程、机器学习或数据科学等领域的研究人员来引领医学物理学定义的变化，从而拓宽新发现和发明的范围。评估研究质量的新方法有助于实现这一模式，重新审视成功和影响的衡量标准。虽然与大型行业的研究伙伴关系是富有成效的，但培育企业初创公司的新努力正在改变机构如何看待学术创新与附属创业公司形成之间联系的好处。这种从创新到企业的重点可以帮助建立更广泛的捐助者到投资者网络。有许多关于医学物理学未来方向的预测，但实际的发明和发现步骤来自于个人的研究人员的创造力。通过DIVERT模式取得的所有成功都要求教师领导的举措跨越从发明到翻译的差距，并在此过程的所有步骤中获得机构领导的支持。通过捐赠或临床收入对教师的机构投资可能需要在未来几年增加，因为赠款的规模相对减少。然而，放射学和放射肿瘤学都是高收入的转化领域，有能力通过互利的大型基础设施协同支持临床和研究业务。这些路线图原则可以为学术领导力中致力于学术医学物理学的项目提供一条途径，这将使医学物理学成为大学学术的一个活跃部分。(C)2021年美国医学物理学家协会
The field of medical physics has struggled with the role of research in recent years, as professional interests have dominated its growth toward clinical service. This article focuses on the subset of medical physics programs within academic medical centers and how a refocused academic mission within these centers should drive and support Discovery and Invention with Ventures and Engineering for Research Translation (DIVERT). A roadmap to a DIVERT-based scholarly research program is discussed here around the core building blocks of: (a) creativity in research and team building, (b) improved quality metrics to assess activity, (c) strategic partnerships and spinoff directions that extend capabilities, and (d) future directions driven by faculty-led initiatives. Within academia, it is the unique discoveries and inventions of faculty that lead to their recognition as scholars, and leads to financial support for their research programs and reconition of their intellectual contributions. Innovation must also be coupled to translation to demonstrate outcome successes. These ingredients are critical for research funding, and the two-decade growth in biomedical engineering research funding is an illustration of this, where technology invention has been the goal. This record can be contrasted with flat funding within radiation oncology and radiology, where a growing fraction of research is more procedure-based. However, some centers are leading the change of the definition of medical physics, by the inclusion or assimilation of researchers in fields such as biomedical engineering, machine learning, or data science, thereby widening the scope for new discoveries and inventions. New approaches to the assessment of research quality can help realize this model, revisiting the measures of success and impact. While research partnerships with large industry are productive, newer efforts that foster enterprise startups are changing how institutions see the benefits of the connection between academic innovation and affiliated startup company formation. This innovation-to-enterprise focus can help to cultivate a broader bandwidth of donor-to-investor networks. There are many predictions on future directions in medical physics, yet the actual inventive and discovery steps come from individual research faculty creativity. All success through a DIVERT model requires that faculty-led initiatives span the gap from invention to translation, with support from institutional leadership at all steps in the process. Institutional investment in faculty through endowments or clinical revenues will likely need to increase in the coming years due to the relative decreasing size of grants. Yet, radiology and radiation oncology are both high-revenue, translational fields, with the capacity to synergistically support clinical and research operations through large infrastructures that are mutually beneficial. These roadmap principles can provide a pathway for committed academic medical physics programs in scholarly leadership that will preserve medical physics as an active part of university academics. (C) 2021 American Association of Physicists in Medicine